In-Silico Structure Database (LMISSD)

Back
Overview
Browse
Search

LMISSD: Sum Composition Results

Abbreviation Formula Mass Main Class Sub Class
GalNAcβ1-3Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O33 1704.007344 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galα1-3Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O33 1704.007344 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-3GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C84H151N3O32 1714.028079 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-3GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C84H153N3O32 1716.043729 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C84H151N3O33 1730.022994 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C84H151N3O33 1730.022994 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C84H151N3O33 1730.022994 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galα1-3Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 44:2;O2 C84H151N3O33 1730.022994 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C84H153N3O33 1732.038644 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C84H153N3O33 1732.038644 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C84H153N3O33 1732.038644 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galα1-3Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 44:1;O2 C84H153N3O33 1732.038644 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 C80H143N3O37 1737.940054 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 C80H143N3O37 1737.940054 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 C82H147N3O37 1765.971354 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 C82H147N3O37 1765.971354 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 C84H151N3O37 1794.002654 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 C84H151N3O37 1794.002654 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 C86H155N3O37 1822.033954 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 C86H155N3O37 1822.033954 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 C88H157N3O37 1848.049604 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 C88H157N3O37 1848.049604 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 C88H159N3O37 1850.065254 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 C88H159N3O37 1850.065254 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C90H161N3O37 1876.080904 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C90H161N3O37 1876.080904 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C90H163N3O37 1878.096554 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C90H163N3O37 1878.096554 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]